Publications by authors named "Mark Robson"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

96

Total Likes

116

Extended Reach

101,454

Social Features

32
K
KEYLYNK-009: Pembrolizumab Plus Olaparib in Locally Recurrent Inoperable or Metastatic Triple-Negative Breast Cancer and Clinical Benefit From First-Line Pembrolizumab Plus Chemotherapy.
Hope S Rugo, David W Cescon, Mark E Robson, Seock-Ah Im, Florence Dalenc

Clin Cancer Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Invasive lobular carcinoma: Strategies and perspectives from the lobular breast cancer research group.
Giovanni Corso, Sherry Shen, Carmen Criscitiello, Rita Mukhtar, Lauren Gamble, Mark E Robson

Cancer Treat Rev· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of Breast Cancer Polygenic Risk Score Disclosure on Decisional Conflict Around Risk-Reducing Mastectomy in Carriers.
Giulia Ongaro, Caroline Salafia, Rania Sheikh, Elizabeth Schofield, Dana Farengo Clark, Mark E Robson

medRxiv· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world evaluation of user engagement with an artificial intelligence-powered clinical trial application in oncology.
Tony K W Hung, Jun J Mao, Alan L Ho, Eric J Sherman, Mark Robson

J Am Med Inform Assoc· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of response to neoadjuvant chemo-immunotherapy in metaplastic triple-negative breast cancer.
Nour Abuhadra, Fresia Pareja, Charlie White, Yuan Chen, Hannah Wen, Mark Robson

NPJ Breast Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective Study of Annual Whole-Body Magnetic Resonance Imaging as Part of a Multimodality Screening Program for Individuals With Li-Fraumeni Syndrome.
Asaf Maoz, Nan Chen, Puja Umaretiya, Sophie R Cahill, Alison Schwartz-Levine, Mark E Robson

JCO Precis Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient characteristics, treatment patterns, and clinical outcomes in HER2-negative early breast cancer by germline BRCA status.
Jay A Andersen, Jagadeswara Rao Earla, Nicole Fulcher, Juliet Ndukum, Nicholas Robert, Mark E Robson

Future Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a Pesticide Labeling Literacy Scale for Thai Rice Farmers: Item Generation and Content Validity Testing.
Phiranut Saeneewong Na Ayuttaya, Nuttaporn Lawthong, Mark Gregory Robson, Wattasit Siriwong

J Agromedicine· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation Between Disease-Free Survival Endpoints and Overall Survival in Elderly Patients with Early-Stage HER2-Negative Breast Cancer: A SEER-Medicare Analysis.
Jagadeswara R Earla, Allison W Kurian, Kalé Kponee-Shovein, Malena Mahendran, Yan Song, Mark Robson

Adv Ther· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional evaluation and clinical classification of BRCA2 variants.
Huaizhi Huang, Chunling Hu, Jie Na, Steven N Hart, Rohan David Gnanaolivu, Mark Robson

Nature· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Automated real-world data integration improves cancer outcome prediction.
Justin Jee, Christopher Fong, Karl Pichotta, Thinh Ngoc Tran, Anisha Luthra, Mark Robson

Nature· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral self-management of palbociclib using mobile technology: Findings from a nurse-led randomized controlled trial.
AnnMarie Mazzella-Ebstein, Margaret Barton-Burke, Venice Anthony, Charlie White, Zhigang Zhang, Mark Robson

Asia Pac J Oncol Nurs· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast Cancer Susceptibility Gene Sequence Variations and Development of Contralateral Breast Cancer.
Anne S Reiner, Gordon P Watt, Kathleen E Malone, Charles F Lynch, Esther M John, Mark E Robson

JAMA Netw Open· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of previous therapy on overall-survival in registration clinical trials for 1st line metastatic breast cancer a systemic review.
Areen Abu Remilah, Bilal Krayim, Eitan Amir, Ariadna Tibau, Mark E Robson

Crit Rev Oncol Hematol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Data from a survey of coffee cultivation in lowland and highland areas to support agriculture during climate change.
Thanapong Chaichana, Graham Reeve, Pairach Piboonrungroj, Jirapond Muangprathub, Jadsada Kunno, Mark Gregory Robson

Data Brief· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of response to CDK4/6i retrial after prior CDK4/6i failure in ER+ metastatic breast cancer.
Nicholas Mai, Carlos H Dos Anjos, Pedram Razavi, Anton Safonov, Sujata Patil, Mark Robson

NPJ Breast Cancer· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of an MRI Radiomic Machine-Learning Model to Predict Triple-Negative Breast Cancer Based on Fibroglandular Tissue of the Contralateral Unaffected Breast in Breast Cancer Patients.
Roberto Lo Gullo, Rosa Elena Ochoa-Albiztegui, Jayasree Chakraborty, Sunitha B Thakur, Mark Robson

Cancers (Basel)· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FLT1 activation in cancer cells promotes PARP-inhibitor resistance in breast cancer.
Yifan Tai, Angela Chow, Seoyoung Han, Courtney Coker, Wanchao Ma, Mark Robson

EMBO Mol Med· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor suppressor heterozygosity and homologous recombination deficiency mediate resistance to front-line therapy in breast cancer.
Anton Safonov, Antonio Marra, Chaitanya Bandlamudi, Ben O'Leary, Bradley Wubbenhorst, Mark E Robson

bioRxiv· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathologic complete response after neoadjuvant systemic therapy for breast cancer in BRCA mutation carriers and noncarriers.
Sara P Myers, Varadan Sevilimedu, Andrea V Barrio, Audree B Tadros, Anita Mamtani, Mark E Robson

NPJ Breast Cancer· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathologic complete response to KEYNOTE522 and HER2-directed therapy for synchronous TNBC and HER2+ breast cancer.
Nicholas Mai, Jie-Fu Chen, Satshil Rana, Mark Robson, Sarat Chandarlapaty

NPJ Precis Oncol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Novel Biomonitoring Method to Detect Pyrethroid Metabolites in Saliva of Occupationally Exposed Workers as a Tool for Risk Assessment.
Melody Wren, Mark Robson, Brian Buckley

Hum Ecol Risk Assess· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimation of Glyphosate biological half-life among farmers and residents in Thailand.
Anusorn Paosungnoen, Pornpimol Kongtip, Noppanun Nankongnab, Sukhontha Siri, Mark Gregory Robson

Hum Ecol Risk Assess· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of Current Areca Nut Use and Its Associated Factors among Bhutanese Aged 15-69 Years: Analysis of the Nationally Representative STEPS Survey 2019.
Tashi Penjor, Mongal Singh Gurung, Mark G Robson, Wattasit Siriwong

WHO South East Asia J Public Health· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis